Glycogen phosphorylase (GP) is the main regulatory enzyme 27 of glycogen metabolism. GP, catalyzing the rate determining 28 step of glycogen degradation in the liver by phosphorolysis, is 29 directly responsible for the regulation of blood glucose levels. 30 Therefore, GP has been a validated target in combating 31 noninsulin-dependent or type 2 diabetes mellitus (T2DM), and 32 its inhibitors are considered as potential antidiabetic agents. 33 The biochemical and pharmacological background of this 34 research has been thoroughly summarized in several reviews of 35 the past decade; therefore, the reader is kindly referred to those 36 papers. 
5-substituted-1,2,4-triazoles were prepared by acylation of O- chemistry, and many drug molecules' activity is due to 17 decreasing the efficiency of these catalytic proteins.
1 In a 18 chemical biological approach, finding an enzyme inhibitor is the 19 result of a good match of the biological and chemical spaces 20 represented by a binding site of an enzyme and a small 21 molecule, respectively, fitting to each other with considerable 22 strength. Among several methods to design inhibitors, 23 bioisosteric replacement of structural elements of existing 24 molecules is widely applied and in many cases results in higher 25 activity or other advantageous property of the new compound. Glycogen phosphorylase (GP) is the main regulatory enzyme 27 of glycogen metabolism. GP, catalyzing the rate determining 28 step of glycogen degradation in the liver by phosphorolysis, is 29 directly responsible for the regulation of blood glucose levels. 30 Therefore, GP has been a validated target in combating 31 noninsulin-dependent or type 2 diabetes mellitus (T2DM), and 32 its inhibitors are considered as potential antidiabetic agents. 33 The biochemical and pharmacological background of this 34 research has been thoroughly summarized in several reviews of 35 Synthesis of the desired 3-glucopyranosyl-5-substituted-1,2,4-84 triazoles of type 6 was planned by adaptation of a literature 85 protocol 32 in which acylation of N 1 -tosylamidrazones gave 3,5-86 disubstituted-1-tosyl-1,2,4-triazoles. Removal of the N-tosyl 87 group was foreseen under conditions usually applied for N-88 desulfonylation of nitrogen heterocycles. To start the syntheses, O-perbenzoylated β-D-glucopyranosyl 90 formimidate 34 9 was reacted with tosylhydrazide to give the s1 91 necessary tosylamidrazone 10 in good yield (Scheme 1). 92 Reaction of 10 with acetyl chloride furnished tosyl-triazole 11a, 93 which was N-detosylated by tetrabutylammonium fluoride 94 (TBAF) to 12a. With acetoxyacetyl chloride 10 gave a mixture 95 of 11b and 12b indicating that the N-tosyl group is prone to 96 splitting off under the acylation conditions. The crude mixture 97 of 11b and 12b was treated with TBAF to produce 12b in 61% 98 yield for the two steps. Acylations of 10 with aromatic acid 99 chlorides were accompanied by complete N-detosylation 100 thereby simplifying the preparation of 12d−f, which were 101 obtained in good yields. Removal of the O-acyl protecting 102 groups was effected under Zempleń conditions to give test 103 compounds 6a and 6c−f in good to excellent yields. 
